• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能不全对自发性细菌性腹膜炎以外的肝硬化合并细菌感染患者的影响。

Impact of renal dysfunction in cirrhotic patients with bacterial infections other than spontaneous bacterial peritonitis.

机构信息

Division of Gastroenterology, Department of Medicine, Buddhist Dalin Tzu Chi General Hospital, Chiayi; School of Medicine, Tzu Chi University.

出版信息

Hepatol Res. 2014 Aug;44(8):863-70. doi: 10.1111/hepr.12190. Epub 2013 Jul 25.

DOI:10.1111/hepr.12190
PMID:23809358
Abstract

AIM

The impact of renal dysfunction has not been well evaluated among cirrhotic patients having bacterial infections other than spontaneous bacterial peritonitis (SBP). We aimed to examine the impact of renal function impairment (RFI) among cirrhotic patients with non-SBP bacterial infections.

METHODS

Data of 7134 cirrhotic patients with non-SBP bacterial infections extracted from the Taiwan National Health Insurance Database, derived from the Taiwan National Health Insurance Program, in 2004 were analyzed.

RESULTS

A total of 579 (8.1%) patients had renal dysfunction. Of these, 223 patients had acute renal failure (ARF), and 141 had end-stage renal disease (ESRD) requiring hemodialysis before admission. The overall 30-day, 1-year and 3-year mortalities were 15.8%, 39.3% and 54.5%, respectively. Compared with the non-RFI group, the adjusted hazard ratios (HR) of 30-day mortality for RFI, ARF and ESRD were 3.20 (P < 0.001), 4.81 (P < 0.001) and 1.59 (P = 0.015); the adjusted HR of 1-year mortality for RFI, ARF and ESRD were 2.68 (P < 0.001), 3.50 (P < 0.001) and 1.84 (P < 0.001), and adjusted HR of 3-year mortality for RFI, ARF and ESRD were 2.34 (P < 0.001), 2.97 (P < 0.001) and 1.76 (P < 0.001). The adjusted HR of 30-day, 1-year and 3-year mortalities for the ARF group were 2.98 (P < 0.001), 1.74 (P < 0.001) and 1.58 (P = 0.001) compared with the ESRD group, respectively.

CONCLUSION

This population-based cohort study shows that RFI, especially ARF, is an independent poor prognostic factor in cirrhotic patients with non-SBP bacterial infections.

摘要

目的

肾功能不全在非自发性细菌性腹膜炎(SBP)的肝硬化患者中的影响尚未得到充分评估。我们旨在研究肾功能损害(RFI)对非 SBP 细菌感染的肝硬化患者的影响。

方法

从 2004 年台湾全民健康保险数据库中提取了 7134 例非 SBP 细菌感染的肝硬化患者的数据,该数据库源自台湾全民健康保险计划。

结果

共有 579 例(8.1%)患者存在肾功能障碍。其中,223 例患者发生急性肾衰竭(ARF),141 例患者在入院前已患有终末期肾病(ESRD)需进行血液透析。总的 30 天、1 年和 3 年死亡率分别为 15.8%、39.3%和 54.5%。与非 RFI 组相比,RFI、ARF 和 ESRD 的 30 天死亡率校正后的危险比(HR)分别为 3.20(P<0.001)、4.81(P<0.001)和 1.59(P=0.015);RFI、ARF 和 ESRD 的 1 年死亡率校正后的 HR 分别为 2.68(P<0.001)、3.50(P<0.001)和 1.84(P<0.001),RFI、ARF 和 ESRD 的 3 年死亡率校正后的 HR 分别为 2.34(P<0.001)、2.97(P<0.001)和 1.76(P<0.001)。与 ESRD 组相比,ARF 组的 30 天、1 年和 3 年死亡率校正后的 HR 分别为 2.98(P<0.001)、1.74(P<0.001)和 1.58(P=0.001)。

结论

这项基于人群的队列研究表明,RFI,尤其是 ARF,是肝硬化非 SBP 细菌感染患者的独立不良预后因素。

相似文献

1
Impact of renal dysfunction in cirrhotic patients with bacterial infections other than spontaneous bacterial peritonitis.肾功能不全对自发性细菌性腹膜炎以外的肝硬化合并细菌感染患者的影响。
Hepatol Res. 2014 Aug;44(8):863-70. doi: 10.1111/hepr.12190. Epub 2013 Jul 25.
2
Effect of renal function impairment on the mortality of cirrhotic patients with hepatic encephalopathy: a population-based 3-year follow-up study.肾功能损害对肝硬化肝性脑病患者死亡率的影响:一项基于人群的3年随访研究
Medicine (Baltimore). 2014 Sep;93(14):e79. doi: 10.1097/MD.0000000000000079.
3
The Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients: A Nationwide Population-Based 3-Year Follow-up Study.肾功能损害对肝硬化患者死亡率的影响:一项基于全国人口的3年随访研究。
PLoS One. 2016 Sep 15;11(9):e0162987. doi: 10.1371/journal.pone.0162987. eCollection 2016.
4
Is end stage renal disease a risk factor for the mortality of cirrhotic patients with esophageal variceal bleeding?终末期肾病是肝硬化食管静脉曲张破裂出血患者死亡的危险因素吗?
Hepatogastroenterology. 2014 Oct;61(135):1871-5.
5
Effect of renal impairment on mortality of patients with cirrhosis and spontaneous bacterial peritonitis.肾功能损害对肝硬化合并自发性细菌性腹膜炎患者死亡率的影响。
Clin Gastroenterol Hepatol. 2012 Jun;10(6):677-81. doi: 10.1016/j.cgh.2012.02.026. Epub 2012 Mar 3.
6
The long-term mortality of spontaneous bacterial peritonitis in cirrhotic patients: A 3-year nationwide cohort study.肝硬化患者自发性细菌性腹膜炎的长期死亡率:一项为期3年的全国性队列研究。
Turk J Gastroenterol. 2015 Mar;26(2):159-62. doi: 10.5152/tjg.2015.4829.
7
The Effect of the First Spontaneous Bacterial Peritonitis Event on the Mortality of Cirrhotic Patients with Ascites: A Nationwide Population-Based Study in Taiwan.首次自发性细菌性腹膜炎事件对肝硬化腹水患者死亡率的影响:台湾一项基于全国人口的研究
Gut Liver. 2016 Sep 15;10(5):803-7. doi: 10.5009/gnl13468.
8
Effect of hypoalbuminemia on mortality in cirrhotic patients with spontaneous bacterial peritonitis.低白蛋白血症对肝硬化自发性细菌性腹膜炎患者死亡率的影响。
Tzu Chi Med J. 2023 Dec 13;36(1):92-97. doi: 10.4103/tcmj.tcmj_211_23. eCollection 2024 Jan-Mar.
9
No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment.在患有食管静脉曲张破裂出血和肾功能损害的肝硬化患者中,特利加压素和生长抑素治疗的死亡率无差异。
Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1275-9. doi: 10.1097/MEG.0000000000000703.
10
High Mortality of Cirrhotic Patients With End-Stage Renal Disease.终末期肾病肝硬化患者的高死亡率
Medicine (Baltimore). 2016 Mar;95(10):e3057. doi: 10.1097/MD.0000000000003057.

引用本文的文献

1
Low-dose Spironolactone Combined with ACEIs/ARBs May Reduce Cardiovascular Events in Patients with CKD Stages 3b-5: A Nationwide Population-Based Cohort Study in Taiwan.低剂量螺内酯联合ACEIs/ARBs可能降低3b-5期慢性肾脏病患者的心血管事件:台湾一项基于全国人群的队列研究
Int J Med Sci. 2025 Feb 24;22(6):1404-1414. doi: 10.7150/ijms.103390. eCollection 2025.
2
Association Between DPP-4 Inhibitors and Events of Colorectal and Liver Cancers in Patients With Diabetes Receiving Second-Line Agents: A Nested Case-Control Study.接受二线药物治疗的糖尿病患者中DPP-4抑制剂与结直肠癌和肝癌事件的关联:一项巢式病例对照研究。
Front Oncol. 2022 May 6;12:840142. doi: 10.3389/fonc.2022.840142. eCollection 2022.
3
Long-Term Effects of Ketoanalogues on Mortality and Renal Outcomes in Advanced Chronic Kidney Disease Patients Receiving a Low-Protein Diet.
长期使用酮酸类似物对接受低蛋白饮食的晚期慢性肾脏病患者的死亡率和肾脏结局的影响。
Nutrients. 2020 Sep 4;12(9):2708. doi: 10.3390/nu12092708.
4
Continuous veno-venous hemofiltration yields better renal outcomes than intermittent hemodialysis among traumatic intracranial hemorrhage patients with acute kidney injury: A nationwide population-based retrospective study in Taiwan.在伴有急性肾损伤的创伤性颅内出血患者中,连续静脉-静脉血液滤过比间歇性血液透析更能改善肾脏结局:来自台湾的一项全国性基于人群的回顾性研究。
PLoS One. 2018 Sep 20;13(9):e0203088. doi: 10.1371/journal.pone.0203088. eCollection 2018.
5
Risks of all-cause mortality and major kidney events in patients with new-onset primary open-angle glaucoma: a nationwide long-term cohort study in Taiwan.在台湾的一项全国性长期队列研究中,新发原发性开角型青光眼患者的全因死亡率和主要肾脏事件风险。
BMJ Open. 2018 Mar 22;8(3):e021270. doi: 10.1136/bmjopen-2017-021270.
6
Association Between Stroke Risk and Metformin Use in Hemodialysis Patients With Diabetes Mellitus: A Nested Case-Control Study.糖尿病血液透析患者中风风险与二甲双胍使用的相关性:巢式病例对照研究。
J Am Heart Assoc. 2017 Nov 16;6(11):e007611. doi: 10.1161/JAHA.117.007611.
7
Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study.他汀类药物与钙通道阻滞剂联合处方后不良事件的风险:一项基于全国人口的研究。
Medicine (Baltimore). 2016 Jan;95(2):e2487. doi: 10.1097/MD.0000000000002487.
8
Increased risks of mortality and atherosclerotic complications in incident hemodialysis patients subsequently with bone fractures: a nationwide case-matched cohort study.新发血液透析患者随后发生骨折时死亡和动脉粥样硬化并发症风险增加:一项全国性病例匹配队列研究。
PLoS One. 2015 Apr 13;10(4):e0121705. doi: 10.1371/journal.pone.0121705. eCollection 2015.